• Do you have a fast to market oncology new products strategy?

    A fast to market strategy offers a number of advantages. Read More

  • Tour De France 2014 Peloton passes Canary Wharf in London

    Who will win the CAR-T cell immunotherapy race to market?

    Novartis, Juno Therapeutics, Kite Pharma, Bluebird Bio & Cellectis are all looking to bring chimeric antigen receptor T-cell (CART) therapies to market. Read More

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

We help Pharma & Biotech companies understand the oncology market, and focus on the right target and commercial opportunity. We offer a range of services that are often combined into custom, hybrid projects:

We frequently work with new products people in prelaunch mode from preclinical to phase II, market researchers and CI teams.

Executive coaching is typically for staff at the Senior Director – Senior VP level who want to ask better strategic questions.